Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Laprevote

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Presse Medicale (Paris, France : 1983)|April 7, 2012
[Abstinence in alcohol-dependence: critical and updated approach of the 2001 national guidelines]Benjamin Rolland, Vincent Laprevote, Pierre Alexis Geoffroy, et al.
Frontiers in Behavioral Neuroscience|April 6, 2016
Commentary: Anatomical constitution of sense organs as a marker of mental disordersThomas Schwitzer, Raymund Schwan, Florent Bernardin, et al.
Neuroscience and Biobehavioral Reviews|February 19, 2019
Cannabis use and human retina: The path for the study of brain synaptic transmission dysfunctions in cannabis usersThomas Schwitzer, Raymund Schwan, Karine Angioi-Duprez, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 25, 2017
Looking into the brain through the retinal ganglion cells in psychiatric disorders: A review of evidencesThomas Schwitzer, Raymund Schwan, Emanuel Bubl, et al.
Frontiers in Psychology|May 9, 2013
Low Spatial Frequency Bias in Schizophrenia is Not Face Specific: When the Integration of Coarse and Fine Information FailsVincent Laprevote, Aude Oliva, Anne-Sophie Ternois, et al.
Therapie|May 29, 2016
[Co-occurrent cannabis and tobacco uses: Clinical knowledge and therapeutic prospects]Thomas Schwitzer, Claudine Gillet, Michaël Bisch, et al.
Biological Psychiatry|November 7, 2012
Per-symptomatic brain activations in alcohol-induced hallucinosisVincent Laprevote, Benjamin Rolland, Olivier Cottencin, et al.
Health and Quality of Life Outcomes|October 27, 2015
Differential item functioning (DIF) of SF-12 and Q-LES-Q-SF items among french substance usersStéphanie Bourion-Bédès, Raymund Schwan, Vincent Laprevote, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 30, 2020
Oscillatory potentials abnormalities in regular cannabis users: Amacrine cells dysfunction as a marker of central dopaminergic modulationLudovic Polli, Raymund Schwan, Eliane Albuisson, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 19, 2017
Cognitive effects of labeled addictolytic medicationsCamille Noélie Pujol, Cecilia Paasche, Vincent Laprevote, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Presse Medicale (Paris, France : 1983)|April 7, 2012
[Abstinence in alcohol-dependence: critical and updated approach of the 2001 national guidelines]Benjamin Rolland, Vincent Laprevote, Pierre Alexis Geoffroy, et al.
Frontiers in Behavioral Neuroscience|April 6, 2016
Commentary: Anatomical constitution of sense organs as a marker of mental disordersThomas Schwitzer, Raymund Schwan, Florent Bernardin, et al.
Neuroscience and Biobehavioral Reviews|February 19, 2019
Cannabis use and human retina: The path for the study of brain synaptic transmission dysfunctions in cannabis usersThomas Schwitzer, Raymund Schwan, Karine Angioi-Duprez, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 25, 2017
Looking into the brain through the retinal ganglion cells in psychiatric disorders: A review of evidencesThomas Schwitzer, Raymund Schwan, Emanuel Bubl, et al.
Frontiers in Psychology|May 9, 2013
Low Spatial Frequency Bias in Schizophrenia is Not Face Specific: When the Integration of Coarse and Fine Information FailsVincent Laprevote, Aude Oliva, Anne-Sophie Ternois, et al.
Therapie|May 29, 2016
[Co-occurrent cannabis and tobacco uses: Clinical knowledge and therapeutic prospects]Thomas Schwitzer, Claudine Gillet, Michaël Bisch, et al.
Biological Psychiatry|November 7, 2012
Per-symptomatic brain activations in alcohol-induced hallucinosisVincent Laprevote, Benjamin Rolland, Olivier Cottencin, et al.
Health and Quality of Life Outcomes|October 27, 2015
Differential item functioning (DIF) of SF-12 and Q-LES-Q-SF items among french substance usersStéphanie Bourion-Bédès, Raymund Schwan, Vincent Laprevote, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 30, 2020
Oscillatory potentials abnormalities in regular cannabis users: Amacrine cells dysfunction as a marker of central dopaminergic modulationLudovic Polli, Raymund Schwan, Eliane Albuisson, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 19, 2017
Cognitive effects of labeled addictolytic medicationsCamille Noélie Pujol, Cecilia Paasche, Vincent Laprevote, et al.
Pageof 5